Skip to content
Compounder

Ingevity Corp

Held by 1 superinvestor (NGVT).

Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.

Valuation

Valuation · two methods

Earnings Power & Asset Floor

Two intrinsic-value methods and a tangible asset floor — deterministic, not price forecasts or recommendations.

In fair-value rangePrice sits within this method’ value estimate.
margin of safety
fair value
above fair value
$72
cheaper$82 – $82 value estimatepricier

Ingevity Corp (NGVT): A conservative earnings-power estimate, $82–$82 / sh; today’s price sits inside it (price $72 as of 2026-07-02).

An observation from two valuation methods — not investment advice, not a buy/sell signal, and not a price target.

Price as of 2026-07-02 · yahoo.

Method & numbers

· Greenwald zero-growth $81.79 · zero-growth base $81.79

Moat Not assessable.

Graham earnings-power value (normalized NOPAT)$67.07 – $81.79 / sh

Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.

Years: 2025, 2024, 2023, 2022, 2021

v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 105% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back).

Buffett owner-earnings value

Normalized owner earnings are non-positive over the years shown; earnings power cannot be capitalized.

Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9–11% rate band (read as a cost-of-equity proxy). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).

Years: 2025, 2024, 2023, 2022, 2021

v1 simplifications: Net income is below its multi-year average (cyclical/declining): normalized owner earnings anchored to the latest year — no peak-earnings capitalization (audit #2). Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the same 9–11% band as a cost-of-equity proxy (theoretically the cost of equity is higher; v2 simplification, v3 to refine).

Asset floor: Reproduction value = tangible net assets (equity − goodwill − intangibles) + capitalized R&D (5y straight-line), ÷ diluted shares.

Moat reading: Franchise test compares earnings power (EPV) against reproduction value (tangible net assets + capitalized R&D). EPV well above reproduction value signals a moat; near it, a commodity; below it, value destruction. A directional reading, not a verdict.

Growth value gated to zero — no moat / ROIIC ≤ WACC, so no growth value is credited.

Window FY 2025, 2024, 2023, 2022, 2021 · discount band 9%11% · normalized tax 21% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.

Ownership · 13F consensus

Who's buying it

Institutional ownership aggregated across funds — consensus strength and this quarter's moves. Describes actions, not advice.

1 superinvestor hold it · $1.2M combined

This quarter1 trimmed

Largest holder Ray Dalio

Held by 1 superinvestor of Ingevity Corp (NGVT); this quarter 1 trimmed (as of 2026-03-31).

13F positions are self-reported and can lag up to 45 days. Informational only — not investment advice.

Next · is it cheap

NGVT's price is not below its conservative value band.

See which stocks are in the strike zone right now

Superinvestors Holding This Security

  • Value$1.2MWeight (prev→now)0.0% 0.0%

Ownership overview

Ingevity Corp (NGVT) is held by 1 of the superinvestors tracked on Compounder, with a combined $1.2M in reported 13F value. The largest position belongs to Ray Dalio, where it makes up 0.0% of the portfolio.

Over the latest quarter, 0 of the tracked filers opened a new position in NGVT, 0 added to existing ones, 1 trimmed, and 0 sold out entirely.

Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-03-31. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.

Holders over time

Superinvestors holding this security over the last 4 quarters: 1 → 1.

Early quarters may understate holder counts due to data backfill — read the slope with care.

Key facts & links

Ticker
NGVT
Total value held
$1.2M
Largest holder
Ray Dalio
External

Sources· SEC EDGAR 13F as of 2026-03-31 · filed 2026-05-15

Related

Stay Updated

Curated 13F moves and valuation insights, straight to your inbox.